Sangamo Therapeutics
SGMO
SGMO
105 hedge funds and large institutions have $26.2M invested in Sangamo Therapeutics in 2025 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 26 increasing their positions, 32 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
less call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
19% less repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 32
38% less capital invested
Capital invested by funds: $42.1M → $26.2M (-$16M)
Holders
105
Holding in Top 10
–
Calls
$535K
Puts
$554K
Top Buyers
| 1 | +$1.21M | |
| 2 | +$1.18M | |
| 3 | +$482K | |
| 4 |
Jane Street
New York
|
+$380K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$307K |
Top Sellers
| 1 | -$1.9M | |
| 2 | -$929K | |
| 3 | -$641K | |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$276K |
| 5 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$269K |
